Mirtazapine: Use of 3.75mg mirtazapine before lights-out during first 2 weeks after TKA surgery. With insufficient effect on sleep, patients are allowed to increase medication to 7.5mg mirtazapine.
Quetiapine: Use of 3.125mg quetiapine before lights-out during first 2 weeks after TKA surgery. With insufficient effect on sleep, patients are allowed to increase medication to 6.25mg mirtazapine.
Placebo: a gelatinous capsule without an active ingredient
Use of mirtazapine and quetiapine for improvement of sleep quality after TKA
| Facility | City | Region | Status |
|---|---|---|---|
| Knowledge Center for Orthopedic Surgery, St. Anna hospital | Geldrop | Netherlands | |
| St. Anna hospital | Geldrop | Netherlands |
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT04728581 on ClinicalTrials.gov ↗ ← All trials in the Netherlands